Privilege not waived by DLA Piper phone call over Circadin patent
Intellectual Property July 27, 2018 11:03 pm By Christine Caulfield | Melbourne

Two generic drug makers have lost their bid for confidential documents related to Neurim Pharmaceuticals’ amendments to patents covering sleep drug Circadin, with a court […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.